Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1978-2025Class II

Brand Name: MiniDock Product Name: Integrated Nucleic Acid Testing Device Model/Catalog Number: PM001...

Guangzhou Pluslife Biotech Co., Ltd. / initiated 2025-01-24 / Open, Classified

Guangzhou Pluslife Biotech Co., Ltd. began a recall of Brand Name: MiniDock Product Name: Integrated Nucleic Acid Testing Device Model/Catalog Number: PM001 Software Version: N/A Product Description: 1. Product... on . FDA classified it as Class II and gives the reason as "Devices were distributed in the U.S. market without obtaining the required FDA premarket authorization (e.g., 510(k) clearance or PMA)". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1978-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Guangzhou Pluslife Biotech Co., Ltd.
Product
Brand Name: MiniDock Product Name: Integrated Nucleic Acid Testing Device Model/Catalog Number: PM001 Software Version: N/A Product Description: 1. Product Overview 1.1 Product Name: Integrated Nucleic Acid Testing Device Brand Name: MiniDock 1.2 Model: PM001 2.Product composition: This device consists of the main unit, power cord, data cable, power adapter, chip bracket, and instruction manual packaging. Component: No
Product code
QKP Coronavirus Antigen Detection Test System.
Reason for recall
Devices were distributed in the U.S. market without obtaining the required FDA premarket authorization (e.g., 510(k) clearance or PMA).
FDA root cause
No Marketing Application
Action
On January 24, 2025, FORMAL NOTICE REGARDING DISTRIBUTION RESTRICTIONS IN THE U.S. MARKET letters were emailed to distributors. This communication serves to formally notify you that, effective immediately, all authorized distributors of Guangzhou Pluslife Biotech Co., Ltd. are strictly prohibited from marketing, selling, or distributing any Pluslife products to the United States market. In May 2025 an "URGENT MEDICAL DEVICE RECALL NOTIFICATION" letters dated May 30, 2025, were sent to the distributor to be sent to consignees. Actions to be taken by the Customer/User: Consumers who still have unused tests manufactured by Pluslife should stop using the device immediately and discard any remaining stock in the trash. - Notice to Distributor: Immediately cease U.S. sales of unauthorized Pluslife devices Issue recall notices to all affected customers in the U.S cooperate fully with the FDA and Pluslife to complete the recall - Company official statement Statement on Prohibition of Unauthorized Sales to the U.S. Market (Published on the Pluslife official website). - Signing the distribution agreement: Prohibiting distributors from selling the unapproved Pluslife products by the FDA in U.S. For assistance, contact: Manufacturer by Pluslife: Marketing Team [email protected] Mon-Fri, 9:00 AM to 6:00 PM CST Distributor by Altruan : After-Sales Team [email protected] Mon-Fri, 9:00 AM to 5:00 PM CET
Quantity in commerce
541 units
Distribution
Worldwide distribution: US (nationwide) and OUS (foreign) to countries of: Hong Kong, Australia, Singapore, Palestine, Russia, Ecuador, Papua New Guinea, Indonesia, South Africa, Zimbabwe, Brazil, Tunisia, Samoa, Algeria, Romania, Czech Republic, Thailand, South Korea, Malaysia, Fiji, Nepal, Peru, Mexico, Bahamas, Chile, India, Germany, France, Portugal, Vietnam, Spain, Poland, Latin American Region, Italy, Cameroon, Slovakia, Greece, Hungary Bahrain, Estonia, and Ukraine.
Product codes and lots
Model/Catalog Number: PM001; Lot numbers: All of the Devices in the U.S.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1978-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1978-2025Class IIOngoingVoluntary: Firm initiated
Z-1979-2025Class IIOngoingVoluntary: Firm initiated